Ménière Disease - Symptoms, Causes, Treatment & Prevention

Overview

Ménière disease (also called Ménière’s disease) is a chronic disorder of the inner ear that causes episodes of vertigo, fluctuating hearing loss, tinnitus (ringing in the ear) and a feeling of fullness in the affected ear. The disease is named after French physician Prosper Ménière, who first described the condition in 1861.

• Who it affects: Adults between 40‑60 years are most commonly diagnosed, but it can occur at any age, including in teenagers.
• Gender: Slightly more common in women (about 55 % of cases).
• Prevalence: Approximately 0.2 %–0.5 % of the population worldwide, corresponding to 1‑2 per 1 000 individuals (Mayo Clinic, 2023).
• Geographic distribution: Similar rates in North America, Europe and Asia; no clear ethnic predilection.

Symptoms

Symptoms often appear in clusters called “episodes” and can last from a few minutes to several hours. Between attacks, many patients experience a residual, fluctuating hearing loss.

Core triad

1. Vertigo – a sensation that you or your surroundings are spinning. Episodes are typically:
   • Sudden onset
   • Severe (can last 20 min–4 h)
   • Accompanied by nausea, vomiting, and imbalance
2. Fluctuating sensorineural hearing loss – usually affects low‑frequency sounds first and may become permanent over time.
3. Tinnitus – a roaring, buzzing, or hissing sound in the affected ear.

Additional symptoms

• Ear fullness or pressure – a sensation of “blocked” ear that can precede vertigo.
• Balance problems – unsteadiness that may continue for days after an episode.
• Headache or neck pain – reported by up to 30 % of patients during attacks.
• Psychological impact – anxiety, depression, or fear of future attacks are common.

Causes and Risk Factors

The exact cause remains unknown, but several mechanisms are strongly implicated.

Proposed pathophysiology

1. Endolymphatic hydrops – abnormal accumulation of fluid (endolymph) in the cochlea and vestibular labyrinth, raising pressure and disrupting hair‑cell function.
2. Autoimmune response – some patients have antibodies that react against inner‑ear antigens.
3. Viral infection – herpes simplex virus type‑1 DNA has been detected in inner‑ear tissue of a minority of cases.
4. Genetic predisposition – family clustering suggests a hereditary component, though no single gene has been identified.

Risk factors

• Age 40‑60 years (peak incidence).
• Female sex.
• History of viral upper‑respiratory infection.
• Allergies or autoimmune disorders (e.g., rheumatoid arthritis, systemic lupus).
• Head trauma or prior ear surgery.
• High-salt diet, caffeine, or alcohol excess – may exacerbate fluid imbalance in susceptible individuals.

Diagnosis

There is no single definitive test for Ménière disease. Diagnosis relies on a combination of clinical history, audiometric findings, and exclusion of other causes.

Diagnostic criteria (AAO‑HNS 2020)

1. Two or more spontaneous vertigo episodes lasting 20 minutes to 12 hours.
2. Fluctuating low‑frequency sensorineural hearing loss documented on audiogram.
3. Tinnitus or aural fullness in the affected ear.
4. Exclusion of alternative diagnoses (e.g., vestibular migraine, acoustic neuroma).

Tests commonly used

• Pure‑tone audiometry – documents baseline hearing loss and monitors progression.
• Electrocochleography (ECoG) – measures electrical potentials; an elevated “SP/AP ratio” supports endolymphatic hydrops.
• Videonystagmography (VNG) / Electronystagmography (ENG) – assesses vestibular function.
• MRI with gadolinium – rules out tumors (e.g., vestibular schwannoma) and can visualize inner‑ear fluid distribution.
• Blood work – thyroid panel, autoimmune markers, and infection serology when indicated.

Treatment Options

Treatment goals are to control vertigo, preserve hearing, and improve quality of life. A stepwise approach is recommended, starting with the least invasive options.

Medications

• Vestibular suppressants (e.g., meclizine, diazepam) – used during acute attacks to reduce nausea and dizziness.
• Diuretics (e.g., hydrochlorothiazide, acetazolamide) – the most widely accepted long‑term therapy; a low‑salt diet enhances effectiveness.
• Corticosteroids (oral prednisone taper or intratympanic dexamethasone) – reduce inflammation and may improve hearing.
• Antiemetics (e.g., ondansetron) – for severe nausea.
• Betahistine – used in some countries to improve microcirculation, though evidence is mixed.

Procedures

1. Intratympanic gentamicin – an aminoglycoside that partially destroys vestibular hair cells, reducing vertigo frequency. Requires careful dosing because it can worsen hearing loss.
2. Endolymphatic sac decompression surgery – relieves fluid pressure; benefits reported in 60‑70 % of selected patients.
3. Labyrinthectomy – removal of vestibular apparatus; reserved for single‑functional ear with debilitating vertigo.
4. Vestibular nerve section – a neurosurgical option for refractory cases when hearing preservation is possible.

Lifestyle and self‑care measures

• Low‑salt diet – ≤1.5 g sodium per day (≈2.5 g salt) reduces fluid retention.
• Hydration balance – avoid rapid fluid shifts (e.g., excessive caffeine or alcohol).
• Stress management – relaxation techniques, yoga, or CBT can lessen attack frequency.
• Regular vestibular rehabilitation therapy (VRT) – exercises improve balance and reduce fall risk.
• Hearing protection – avoid loud noises; consider hearing aids when hearing loss stabilises.

Living with Ménière Disease

Although Ménière disease is chronic, many people lead active lives with proper management.

Daily management tips

1. Track attacks – use a diary (date, time, duration, triggers, medications) to identify patterns.
2. Medication schedule – take diuretics at the same time each day; keep rescue meds (anti‑vertigo pills) within reach.
3. Dietary vigilance – meal‑prep low‑salt meals; read labels for hidden sodium.
4. Safe home environment – install grab bars, use non‑slip mats, keep lighting adequate to prevent falls during an episode.
5. Work accommodations – discuss flexible scheduling or remote work options during periods of instability.
6. Support networks – join Ménière support groups (e.g., Meniere’s Society) for shared coping strategies.

Hearing aids and assistive devices

When hearing loss stabilises, a properly fitted hearing aid can improve speech understanding and reduce tinnitus perception. In bilateral cases, bone‑anchored hearing systems or cochlear implants may be considered.

Psychological well‑being

Because unpredictable vertigo can cause anxiety, referral to a mental‑health professional for counseling, cognitive‑behavioral therapy, or medication is often beneficial.

Prevention

Since the exact cause is unknown, primary prevention is limited. However, risk reduction strategies are useful, especially for those with a family history.

• Maintain a low‑sodium diet and limit caffeine/alcohol.
• Stay well‑hydrated but avoid rapid fluid intake spikes.
• Manage allergies and sinus infections promptly; chronic inflammation may contribute to inner‑ear fluid dysregulation.
• Protect ears from excessive noise to preserve residual hearing.
• Consider regular medical check‑ups if you have autoimmune disease or a close relative with Ménière disease.

Complications

If left uncontrolled, Ménière disease can lead to:

• Permanent hearing loss – up to 40 % of patients develop severe, irreversible loss in the affected ear.
• Chronic imbalance – persistent unsteadiness that increases fall risk, especially in older adults.
• Social isolation – fear of attacks may limit participation in work, travel, or social events.
• Psychiatric comorbidities – heightened prevalence of depression and anxiety (estimated 30‑45 % of patients).
• Medication side effects – long‑term diuretic use can cause electrolyte disturbances; vestibular‑ablative procedures may cause total loss of vestibular function.

When to Seek Emergency Care

References

• Mayo Clinic. “Meniere’s disease.” Updated 2023. https://www.mayoclinic.org
• National Institute on Deafness and Other Communication Disorders (NIDCD). “Meniere’s Disease.” 2022. https://www.nidcd.nih.gov
• American Academy of Otolaryngology–Head and Neck Surgery (AAO‑HNS). Clinical practice guideline: “Meniere’s Disease.” 2020.
• Cleveland Clinic. “Meniere’s disease: Diagnosis and treatment.” 2023. https://my.clevelandclinic.org
• World Health Organization. “Ear and hearing disorders.” 2021. https://www.who.int